Announcement on Resignation of Independent Director
Filed with SSE · · 2 pages · Chinese
Summary by 6ix AI
Chongqing Genrix Biopharmaceutical Co., Ltd. announced the resignation of independent director Hu Yuntong due to work reasons.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Chongqing Genrix Biopharmaceutical Co., Ltd. on 6ix
Earlier from Chongqing Genrix Biopharmaceutical
- Announcement on Voluntary Disclosure of Inclusion GR1803 Injection in the List of Priority Review Drugs
- Announcement on Voluntary Disclosure on the Acceptance of Conditional Listing Application for GR1803 Injection
- Announcement on Changing Signatory Certified Public Accountant
- Announcement on Voluntary Disclosure of the Inclusion of the Xeligekimab Injection in the 2025 National Medical Insurance Catalog
- Announcement on Resolutions of the 5th Meeting of the 2nd Board of Directors
Later from Chongqing Genrix Biopharmaceutical
- Earnings Preannouncement for 2025
- Announcement on Resolutions of the 6th Meeting of the 2nd Board of Directors
- Announcement on Voluntary Disclosure on Acceptance of Marketing Application for Tallecimab Injection for Adult Seasonal Allergic Rhinitis
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Announcement on Opening of a New Special Account for Raised Funds and Signing of a Tripartite Supervision Agreement on Special Account Deposit of Raised Funds
Follow Chongqing Genrix Biopharmaceutical into a list and get an email when it puts out news.
Follow Chongqing Genrix Biopharmaceutical